择期EVAR与长期肾功能下降:基于硬性肾脏结局的分析
该研究基于单中心前瞻性数据库,纳入275例接受择期EVAR且随访超过5年的患者,使用eGFR评估肾功能变化。中位随访9年,eGFR从术前67 mL/min/1.73 m2降至52 mL/min/1.73 m2,年均下降1.7单位,2%患者需RRT;eGFR下降超20%者死亡风险增高(OR 3.3,p < .001)。提示EVAR后存在显著长期肾功能下降,年轻患者选择EVAR时需权衡。
要点
- 择期EVAR后中位9年eGFR年均下降1.7 mL/min/1.73 m2,需重视长期肾功能监测。
- eGFR较基线下降超20%者晚期死亡风险增高(OR 3.3,p < .001)。
- 年轻患者选择EVAR时应将长期肾功能下降纳入决策考量。
核心结论
- 择期EVAR后患者可能经历显著的长期肾功能下降,年轻患者选择EVAR时需考虑此风险并优化肾脏随访与保护。
研究设计与样本
- 单中心前瞻性维护数据库的回顾性队列分析,纳入2000年1月至2010年7月连续接受择期EVAR且随访超过5年、既往未接受肾脏替代治疗的患者275例(女性23例,8%;平均年龄75岁)。
主要发现
- 中位随访9年(范围5-17年),平均eGFR从术前67 mL/min/1.73 m2(SD 9.4)降至52 mL/min/1.73 m2(SD 7.7),年均下降1.7单位。
- 晚期随访期间6例(2%)需肾脏替代治疗(透析)。
- 需RRT者及末次随访eGFR较基线下降超过20%者晚期死亡风险更高(OR分别为2.4和3.3,p < .001)。
临床怎么用
- 对接受EVAR的患者应进行长期肾功能监测,尤其关注eGFR下降超过20%的高危患者。
- 在年轻患者中提供EVAR时应充分告知长期肾功能下降风险,并优化肾脏保护策略。
局限性
- 单中心回顾性设计,样本量有限(275例),可能存在选择偏倚。
- 随访时间跨度大(2000-2010年入组),EVAR技术与器械可能随时间变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Over the short term endovascular aneurysm repair (EVAR) is associated with superior outcomes compared with open repair; however, the progression of renal function after EVAR remains unknown because of the use of inconsistent reporting measures. The aim was to define long term renal decline following elective EVAR using estimated glomerular filtration rate (eGFR). METHODS: The prospectively maintained in house database was used to identify consecutive patients having elective EVAR who had been followed up for more than five years. Overall, 275 patients (23 females, 8%; mean age, 75 years) who were not previously on renal replacement therapy (RRT) were included (January 2000 to July 2010). Pre-operative, post-operative, and most recent eGFR values were evaluated using the chronic kidney disease epidemiology collaboration equation. The primary outcome was change in eGFR at latest follow up. RESULTS: Patients were followed up over a median of 9 years (range 5-17 years). Their mean eGFR dropped from a pre-operative value of 67 mL/min/1.73 m2 (standard deviation [SD]: 9.4) to 52 mL/min/1.73 m2 (SD 7.7), which amounts to a yearly loss of 1.7 units; six patients (2%) required RRT (dialysis) during late follow up. Patients requiring RRT and those with an eGFR loss exceeding 20% at latest follow up compared with baseline were more likely to die during late follow up (odds ratio 2.4 and 3.3 respectively, p < .001). CONCLUSION: This analysis, with some of the longest available follow up to date, suggests that patients undergoing EVAR may experience a significant long term decrease in renal function. This needs to be taken into account when offering EVAR in younger patients; renal follow up and preservation should be optimised in this patient group.
引用
- Charles ER, Lui D, Delf J, et al. Editor's Choice - The Impact of Endovascular Aneurysm Repair on Long Term Renal Function Based on Hard Renal Outcomes. Eur J Vasc Endovasc Surg. 2019. PMID: 31327538. doi:10.1016/j.ejvs.2019.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。